The side effects of the prostaglandin analogues

G Holló - Expert opinion on drug safety, 2007 - Taylor & Francis
In the last decade topically applied prostaglandin F2α analogues (bimatoprost, latanoprost,
travoprost and unoprostone) have become widely used as a means to reduce elevated …

[HTML][HTML] Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma

L Zhou, W Zhan, X Wei - Frontiers in Pharmacology, 2022 - frontiersin.org
Glaucoma is the main cause of irreversible visual loss worldwide, and comprises a group of
progressive, age-related, and chronic optic neuropathies. Prostaglandin analogs are …

Myopia: attempts to arrest progression

SM Saw, G Gazzard, KGA Eong… - British Journal of …, 2002 - bjo.bmj.com
Previous studies have evaluated the efficacy of several interventions to decrease the
progression of myopia. These include devices that alter the perception of the visual …

Medical interventions for primary open angle glaucoma and ocular hypertension

C Vass, C Hirn, T Sycha, O Findl… - Cochrane Database …, 2007 - cochranelibrary.com
Background Primary open angle glaucoma (POAG) is a progressive optic neuropathy with
an elevated intraocular pressure (IOP), where the optic nerve head becomes pathologically …

Latanoprost: an update of its use in glaucoma and ocular hypertension

CM Perry, JK McGavin, CR Culy, T Ibbotson - Drugs & aging, 2003 - Springer
Latanoprost (Xalatan®) is an ester analogue of prostaglandin F 2α that reduces intraocular
pressure (IOP) by increasing uveoscleral outflow. The IOP-lowering efficacy of latanoprost …

Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects

T Nieminen, T Lehtimäki, J Mäenpää… - … journal of clinical and …, 2007 - Taylor & Francis
Timolol maleate is a non‐selective β‐adrenoceptor antagonist currently used mainly as an
ocular preparation for the treatment of glaucoma and ocular hypertension. Despite the …

A review of the use of latanoprost for glaucoma since its launch

M Digiuni, P Fogagnolo, L Rossetti - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Prostaglandins are increasingly used as first choice treatment for glaucoma
because they are highly effective, lack relevant systemic side effects and require just once …

[HTML][HTML] Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in children

RJC Bowman, J Cope, KK Nischal - Eye, 2004 - nature.com
Abstract Introduction Brimonidine 0.2%(Alphagan®) is a topical alpha-2 agonist widely used
as an antihypertensive. There have been occasional reports of systemic adverse effects in …

Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms

S Deokule, S Sadiq, S Shah - Ophthalmic and Physiological …, 2004 - Wiley Online Library
Purpose: To study the awareness of the nature of the disease, compliance with treatment,
and prevalence of systemic symptoms in a group of patients with chronic open angle …

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension

AJ Lee, P McCluskey - Clinical Ophthalmology, 2010 - Taylor & Francis
Prostaglandin analogs (PGA) are powerful topical ocular hypotensive agents available for
the treatment of elevated intraocular pressure (IOP). Latanoprost 0.005% and travoprost …